Literature DB >> 11451709

Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.

D De Mouy1, J D Cavallo, R Leclercq, R Fabre.   

Abstract

Among 126 Streptococcus agalactiae isolates collected in 10 French laboratories in 1999, 27 (21.4%) had macrolide resistance related to the presence of erm(B) (11 strains), erm(A) subclass erm(TR) (10 strains), and mef(A) genes (2 strains) and the presence of combinations of erm(B) and erm(A) genes or mef(A) genes (3 strains).

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11451709      PMCID： PMC90666          DOI： 10.1128/AAC.45.8.2400-2402.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  Change in antibiotic resistance of group B streptococcus: impact on intrapartum management.

Authors:  W J Morales; S S Dickey; P Bornick; D V Lim
Journal:  Am J Obstet Gynecol       Date:  1999-08       Impact factor: 8.661

2.  Presence of mefA and mefE genes in Streptococcus agalactiae.

Authors:  C Arpin; H Daube; F Tessier; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.

Authors:  C Betriu; M Redondo; M L Palau; A Sánchez; M Gómez; E Culebras; A Boloix; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

4.  Antibiotic resistance patterns of group B streptococci in pregnant women.

Authors:  K Berkowitz; J A Regan; E Greenberg
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

5.  Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

Authors:  C Betriu; M Gomez; A Sanchez; A Cruceyra; J Romero; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Observatoire de Normandie du Pneumocoque.

Authors:  P Angot; M Vergnaud; M Auzou; R Leclercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-10       Impact factor: 3.267

7.  Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

Authors:  F Y Lin; P H Azimi; L E Weisman; J B Philips; J Regan; P Clark; G G Rhoads; J Clemens; J Troendle; E Pratt; R A Brenner; V Gill
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

8.  Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

Authors:  J Clancy; J Petitpas; F Dib-Hajj; W Yuan; M Cronan; A V Kamath; J Bergeron; J A Retsema
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

9.  Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.

Authors:  A Tait-Kamradt; T Davies; P C Appelbaum; F Depardieu; P Courvalin; J Petitpas; L Wondrack; A Walker; M R Jacobs; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

10.  Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-05-31
View more
  19 in total

1.  Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.

Authors:  Daniel J Diekema; Janet I Andrews; Holly Huynh; Paul R Rhomberg; Stella R Doktor; Jill Beyer; Virginia D Shortridge; Robert K Flamm; Ronald N Jones; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

2.  Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital.

Authors:  Claire Poyart; Laurence Jardy; Gilles Quesne; Patrick Berche; Patrick Trieu-Cuot
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

3.  Antimicrobial susceptibilities of group B streptococci in New Zealand.

Authors:  Anja M Werno; Trevor P Anderson; David R Murdoch
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

4.  Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital.

Authors:  Ziya Cibali Acikgoz; Ebru Almayanlar; Sohret Gamberzade; Safiye Gocer
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

5.  Environmental impact assessment of Attenda abattoir, Ogbomoso southwestern Nigeria on surface and groundwater quality using geo-electrical imaging and microbiological analysis.

Authors:  Olawale Olufemi Adelowo; Ismail A Akinlabi; Obasola Ezekiel Fagade
Journal:  Environ Monit Assess       Date:  2011-11-22       Impact factor: 2.513

6.  Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.

Authors:  V Lavergne; M Laverdière; A Duchesne; C Béliveau; J Delorme; A Di Zazzo; A C Labbé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

7.  Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources.

Authors:  Rafael S Duarte; Bruna C Bellei; Otávio P Miranda; Maria A V P Brito; Lúcia M Teixeira
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

8.  Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations.

Authors:  Jason E Bowling; Aaron E Owens; M Leticia McElmeel; Letitia C Fulcher; Monica L Herrera; Brian L Wickes; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

9.  Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections.

Authors:  James S Lewis; Alex J Lepak; George R Thompson; William A Craig; David R Andes; Kathryn E Sabol-Dzintars; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

10.  Invasive group B streptococcal infection in infants, Malawi.

Authors:  Katherine J Gray; Sally L Bennett; Neil French; Amos J Phiri; Stephen M Graham
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.